Category Industry Updates

PHCbi Introduces LiCellGrow™ Cell Expansion System to Advance Efficient, High-Quality Cell and Gene Therapy Manufacturing

Introduction to PHCbi’s Latest Innovation in Cell Expansion PHC Corporation’s Biomedical Division (PHCbi), headquartered in Tokyo’s Chiyoda-ku district and led by President Nobuaki Nakamura, has announced the launch of its innovative cell expansion system, LiCellGrow™. As a subsidiary of PHC…

Read MorePHCbi Introduces LiCellGrow™ Cell Expansion System to Advance Efficient, High-Quality Cell and Gene Therapy Manufacturing

PVP Labs Highlights Peptide Pipeline and Taphalgin® at LSX Investival USA in Miami

PVP Labs Selected to Present at LSX Investival Showcase USA 2026 in Miami PVP Labs, an emerging biotechnology innovator focused on peptide-based drug development, has been selected to present at the prestigious LSX Investival Showcase USA, scheduled for March 10–11,…

Read MorePVP Labs Highlights Peptide Pipeline and Taphalgin® at LSX Investival USA in Miami

PPG, IPG Photonics and Whirlpool Partner to Fast-Track Breakthrough Laser Powder Curing Technology

Strategic Collaboration Between PPG, IPG Photonics and Whirlpool Corporation PPG today announced a strategic collaboration with IPG Photonics, widely recognized as the global leader in fiber laser technology, and Whirlpool Corporation, one of the world’s most prominent home appliance manufacturers,…

Read MorePPG, IPG Photonics and Whirlpool Partner to Fast-Track Breakthrough Laser Powder Curing Technology

ZOLL Drives Asahi Kasei Healthcare Growth with U.S. Launch of Next-Gen LifeVest

New LifeVest WCD and redesigned garment enhance comfort and strengthen ZOLL’s market leadership Asahi Kasei has announced a major milestone in its healthcare business with the U.S. launch of the next-generation LifeVest® wearable cardioverter defibrillator (WCD) by its subsidiary, ZOLL®…

Read MoreZOLL Drives Asahi Kasei Healthcare Growth with U.S. Launch of Next-Gen LifeVest
ConcertAI’s TeraRecon Surpasses 2,000 Customers

ConcertAI’s TeraRecon Surpasses 2,000 Customers, Driving Cloud-First SaaS in Healthcare

ConcertAI’s TeraRecon, a leading provider of AI-powered advanced visualization (AV) and clinical workflow solutions, today announced it has surpassed 2,000 global customers. This milestone underscores the continued acceleration of TeraRecon’s cloud-first SaaS transformation, reflecting strong adoption across clinical imaging domains…

Read MoreConcertAI’s TeraRecon Surpasses 2,000 Customers, Driving Cloud-First SaaS in Healthcare
VectorY and Shape Therapeutics Partner to Develop

VectorY and Shape Therapeutics Partner to Develop AAV5-Based Antibody Therapies for Neurodegenerative Diseases

VectorY Therapeutics, a biotechnology company pioneering vectorized antibody therapies for neurodegenerative diseases, and Shape Therapeutics Inc. (“ShapeTX”), a leader in applying AI and RNA technologies to engineer next-generation genetic medicines, announced today that they have entered into an option and…

Read MoreVectorY and Shape Therapeutics Partner to Develop AAV5-Based Antibody Therapies for Neurodegenerative Diseases